生物
细胞毒性T细胞
脾脏
淋巴因子激活杀伤细胞
白血病
NK-92
骨髓
分子生物学
自然杀伤细胞
细胞溶解
免疫学
自然杀伤性T细胞
抗体
淋巴结
肿瘤
白细胞介素21
体外
生物化学
遗传学
作者
Rolf Kiessling,Eva Klein,Hugh F. Pross,Hans Wigzell
标识
DOI:10.1002/eji.1830050209
摘要
Abstract Normal mice contain cytolytic cells with specificity for in vitro grown mouse Moloney leukemia cells. Such killer cells are most frequent in the spleens; lymph node and bone marrow contain less and thymus virtually no killer activity. Peak activity is found around one to three months of age. Spleen cells from genetically athymic mice are as active killer cells as those from normal mice of the same strain. Treatment with anti‐theta serum plus complement followed by removal of adherent and surface Ig positive cells by filtration through anti‐Ig columns will leave between 1–5 % of the original spleen cell population from a normal mouse. These cells have the morphology of small lymphocytes and perhaps contain all of the total original killer activity of the spleen against the Moloney leukemia cells. Such killer enriched cells are devoid of T and B lymphocytes and largely fail to function in antibody induced, cell‐mediated lysis against antibody‐coated chicken erythrocytes. It is concluded that the spontaneous selective cytotoxic activity of normal mouse spleen cells against Moloney leukemia cells is exerted by small lymphocytes of yet undefined nature.
科研通智能强力驱动
Strongly Powered by AbleSci AI